INDICATIONS AND USAGE
Glatzi is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, and active secondary progressive disease, in adults.
DOSAGE AND ADMINISTRATION
For subcutaneous injection only
Glatzi 40 mg/ml three times per week.
DOSAGE FORMS AND STRENGTHS
For injection: 40 mg/ml in a single-dose, prefilled syringe with an orange plunger.
STORAGE OF GLATZI
Keep Glatzi in a refrigerator (2 to 8 degrees of centigrade).